Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 2 de 2
Filter
Add more filters










Database
Language
Publication year range
1.
Appl Radiat Isot ; 176: 109874, 2021 Oct.
Article in English | MEDLINE | ID: mdl-34311218

ABSTRACT

The radiochemical purity (RCP) determination of radiopharmaceuticals is routinely done with radio-thin layer chromatography (r-TLC). These methods are usually transposed and adjusted from the summary product characteristics without any analytical validation. The r-TLC method is simple but manually-performed steps could lead to RCP misinterpretation. To increase the sensitivity, radio ultra-high performance liquid chromatography (r-UHPLC) can be used. In this study, an r-UHPLC method had been validated and compared to the r-TLC method. Hydrolyzed-reduced technetium had also been studied.


Subject(s)
Chromatography, High Pressure Liquid/methods , Quality Control , Radiopharmaceuticals/chemistry , Technetium/chemistry , Chromatography, Thin Layer/methods
2.
J Pharm Sci ; 98(12): 4650-60, 2009 Dec.
Article in English | MEDLINE | ID: mdl-19492342

ABSTRACT

The (99m)Tc-tricarbonyl core may be used as an ideal tool for gamma-labeling ligands in noninvasive SPECT imaging. However, most (99m)Tc-tricarbonyl-labeled agents have difficulty crossing the blood-brain barrier (BBB). We radiolabeled the neuroactive indole ibogaine with (99m)Tc-tricarbonyl and measured its transport into the mouse brain by in situ brain perfusion. We measured the interactions of [(99m)Tc(CO)(3)-ibogaine](+) and (99m)Tc-tricarbonyl with the main BBB efflux transporters P-gp and BCRP in vitro and in vivo. Ibogaine was radiolabeled (yield: over 95%). [(99m)Tc(CO)(3)-ibogaine](+) entered the brain (K(in)) poorly (0.18 microL/g/s), at about the same rate as (99m)Tc-tricarbonyl (0.16 microL/g/s) and [(99m)Tc-sestamibi](+) (0.10 microL/g/s). The CNS tracer [(99m)Tc-HMPAO](0) entered the brain approximately 70-times higher than [(99m)Tc(CO)(3)-ibogaine](+). In vitro studies revealed that neither [(99m)Tc(CO)(3)-ibogaine](+) nor (99m)Tc-tricarbonyl ion were substrates for P-gp or BCRP. But lowering the membrane dipole potential barrier with phloretin enhanced the brain transport of [(99m)Tc(OH(2))(3)(CO)(3)](+) approximately 3-fold. Thus, ibogaine directly labeled with (99m)Tc-tricarbonyl is not suitable for CNS imaging because of its poor uptake. Brain transport is not restricted by efflux transporters but is reduced by its lipophilicity and interaction with the membrane-positive dipole potential.


Subject(s)
Ibogaine/analogs & derivatives , Ibogaine/chemistry , Organotechnetium Compounds/chemical synthesis , Radiopharmaceuticals/chemical synthesis , ATP Binding Cassette Transporter, Subfamily B, Member 1/metabolism , ATP Binding Cassette Transporter, Subfamily G, Member 2 , ATP-Binding Cassette Transporters , Animals , Biological Transport, Active , Blood-Brain Barrier , Blotting, Western , Brain/metabolism , Brain Chemistry/genetics , Cells, Cultured , Chromatography, Thin Layer , Humans , Hydrogen-Ion Concentration , Ibogaine/chemical synthesis , Ibogaine/pharmacokinetics , Indoles/chemistry , Isotope Labeling , Male , Mice , Organotechnetium Compounds/pharmacokinetics , Radiopharmaceuticals/pharmacokinetics , Technetium
SELECTION OF CITATIONS
SEARCH DETAIL
...